Immunogenicity and Safety of a Virosomal Hepatitis A Vaccine (Epaxal®) in the Elderly-Reference-Cited by-同舟云学术

Immunogenicity and Safety of a Virosomal Hepatitis A Vaccine (Epaxal®) in the Elderly

Published:2006-03-01 Issue:2 Volume:13 Page:78-83
ISSN:1195-1982
Container-title:Journal of Travel Medicine
language:en
Short-container-title:J Travel Med

Author:

D’Acremont Valérie,Herzog Christian,Genton Blaise

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Link

http://academic.oup.com/jtm/article-pdf/13/2/78/5161341/jtm13-0078.pdf

Reference29 articles.

1. Hepatitis A

2. Epidemiology and Prevention of Hepatitis A in Travelers

3. Serious Hepatitis A: An Analysis of Patients Hospitalized during an Urban Epidemic in the United States

4. Forbes A Williams R . Increasing age—An important adverse prognostic factor in hepatitis A virus infection. J R Coll Physicians Lond 1988; 22: 237–239.

5. Hill DR . Health problems in a large cohort of Americans traveling to developing countries. J Travel Med 2000; 7: 259–266.

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coadministered pneumococcal conjugate vaccine decreases immune response to hepatitis A vaccine: a randomized controlled trial;Clinical Microbiology and Infection;2023-12

2. Clinical applications and future clinical trials of the drug delivery system;Nanotechnology for Drug Delivery and Pharmaceuticals;2023

3. Drug Delivery through Liposomes;Smart Drug Delivery;2022-07-06

4. Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study);eClinicalMedicine;2022-04

5. The liver and gallbladder in the geriatric population;Pathy's Principles and Practice of Geriatric Medicine;2022-02-18